Shopping Cart
- Remove All
- Your shopping cart is currently empty
Edotecarin is a potent topoisomerase I inhibitor. It can decrease single-strand DNA cleavage (IC50: 50 nM).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 2.156 € | 10-14 weeks | |
50 mg | 2.831 € | 10-14 weeks | |
100 mg | 3.800 € | 10-14 weeks |
Description | Edotecarin is a potent topoisomerase I inhibitor. It can decrease single-strand DNA cleavage (IC50: 50 nM). |
Targets&IC50 | Topo I:50 nM, PKC:160 μM |
In vitro | Edotecarin (0.6 μmol/L) increases the formation of DNA-protein complexes in a time-dependent manner, in the presence of human colon cancer cells labeled with 3Hthymidine [1]. |
In vivo | Edotecarin significantly delays tumor growth, achieving a delay of 10.45 days at a dosage of 3 mg/kg and extending up to 24.83 days at 100 mg/kg. It enhances survival by 83% in mice with D-456MG glioma intracranial tumors and exhibits potent antimetastatic properties [1]. Additionally, combining edotecarin with irinotecan elevates its in vivo antitumor efficacy beyond that observed with either compound individually [2]. |
Alias | PF 804950, J 107088 |
Molecular Weight | 608.55 |
Formula | C29H28N4O11 |
Cas No. | 174402-32-5 |
Relative Density. | 1.96g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.